SFI
ORIC icon

Susquehanna Fundamental Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,518
Closed -$209K – 640
2025
Q4 		$209K Hold
25,518
– – 0.01% 509
2025
Q3 		$306K Sell
25,518
-17,875
-41% -$188K 0.01% 479
2025
Q2 		$440K Sell
43,393
-25,643
-37% -$172K 0.01% 572
2025
Q1 		$385K Buy
69,036
+48,761
+240% +$426K 0.01% 902
2024
Q4 		$164K Buy
+20,275
New +$186K ﹤0.01% 1021
2022
Q1 		$73K Sell
13,643
-12,900
-49% -$116K ﹤0.01% 1476
2021
Q4 		$390K Buy
26,543
+5,144
+24% +$80.2K 0.01% 1018
2021
Q3 		$447K Buy
+21,399
New +$434K 0.01% 1259

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return